{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T20:15:52Z","timestamp":1775938552294,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jdiacomp.2019.05.026","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T11:34:42Z","timestamp":1559907282000},"page":"634-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Metabolic health and vascular complications in type 1 diabetes"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-4389","authenticated-orcid":false,"given":"Sandhya","family":"Bhattarai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian F.","family":"Godsland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond G.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF00398055","article-title":"Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study","volume":"37","author":"Stephenson","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0010","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.2337\/diacare.27.2007.S84","article-title":"Retinopathy in diabetes","volume":"27","author":"Fong","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0015","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc10-S011","article-title":"Standards of medical care in diabetes\u20142010","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0020","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc11-1108","article-title":"Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K","volume":"34","author":"Abbott","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0025","first-page":"1110","article-title":"Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association","volume":"130","author":"de Ferranti","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0035","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0040","author":"The National Institute for Health and Care Excellence"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0045","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archinternmed.2009.193","volume":"169","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Research Group","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diacare.27.2.530","article-title":"Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study","volume":"27","author":"Soedamah-Muthu","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0060","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/j.orcp.2013.03.007","article-title":"Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes","volume":"8","author":"Price","year":"2014","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0065","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2337\/diacare.28.7.1649","article-title":"Impact of overweight on chronic microvascular complications in type 1 diabetic patients","volume":"28","author":"De Block","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0070","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-5491.2000.00372.x","article-title":"Predictors of mortality and end-stage diabetic complications in patients with type 1 diabetes mellitus on intensified insulin therapy","volume":"17","author":"M\u00fchlhauser","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0075","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db15-1517","article-title":"Risk factors for cardiovascular disease in type 1 diabetes","volume":"65","author":"Nathan","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0300-8932(10)70063-4","article-title":"Metabolic syndrome and type-1 diabetes mellitus: prevalence and associated factors","volume":"63","author":"Chillar\u00f3n","year":"2010","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0085","series-title":"Dyslipidemia management in adults with diabetes","author":"Haffner","year":"2004"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0095","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0100","author":"International Diabetes Federation"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0105","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2337\/diacare.24.6.1053","article-title":"Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"24","author":"Orchard","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/460321","article-title":"All-cause mortality risk of metabolically healthy obese individuals in NHANES III","volume":"2012","author":"Durward","year":"2012","journal-title":"J Obes"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0115","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/dc12-1654","article-title":"Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?","volume":"36","author":"Hinnouho","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0120","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00431-015-2587-4","article-title":"Preserved insulin sensitivity predicts metabolically healthy obese phenotype in children and adolescents","volume":"174","author":"Vukovic","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1464-5491.2003.01029.x","article-title":"Characteristics of type 1 diabetes of over 50\u202fyears duration (the Golden Years Cohort)","volume":"20","author":"Bain","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0130","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2337\/dc06-2222","article-title":"Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study","volume":"30","author":"Keenan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0135","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2337\/dc06-0942","article-title":"The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey","volume":"29","author":"Metascreen Writing Committee","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0140","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2337\/diacare.28.8.2019","article-title":"Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study)","volume":"28","author":"Thorn","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0145","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2337\/dc16-0102","article-title":"Commonly measured clinical variables are not associated with burden of complications in long-standing type 1 diabetes: results from the Canadian study of longevity in diabetes","volume":"39","author":"Weisman","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ndt\/gfg421","article-title":"Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor?","volume":"19","author":"Rabelink","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jacl.2011.06.011","article-title":"High-density lipoprotein cholesterol in diabetes: is higher always better?","volume":"5","author":"Costacou","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jdiacomp.2019.05.026_bb0160","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What's wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872718312832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872718312832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:09:10Z","timestamp":1761005350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872718312832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1056872718312832"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.05.026","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic health and vascular complications in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 All rights reserved.","name":"copyright","label":"Copyright"}]}}